摘要
氧化应激和神经炎症与包括老年痴呆(AD)的多种神经退行性疾病的病理过程高度相关。(+)-2-(1-羟基-4-环氧己基)咖啡酸乙酯(HOEC),一种新5脂氧合酶抑制剂,是从Incarvillea mairei var. granditlora (Wehrhahn) Grierson全草中分离出的。我们研究了HOEC在体内和体外对抗过氧化氢(H2O2)和脂多糖(LPS)诱导的细胞毒性和神经炎症的保护作用。我们进行了MTT试验,LDH释放试验,形态学观察和Hoechst 33342/PI双染色结合EIA,免疫荧光染色和蛋白免疫印迹分析,以说明HOEC的神经保护作用。在H2O2暴露前的HOEC多浓度处理显著增强了细胞生存力,减少了LDH释放,防止了细胞的形态变化和凋亡。HOEC显著地抑制了LTB4的产生和巨噬细胞介导的神经毒性,而不是PGE2的减少。蛋白免疫印迹和免疫荧光染色显示HOEC抑制了H2O2诱导的p38磷酸化和NF-κB活化。HOEC的神经保护作用被p38抑制剂消除。我们发现了HOEC防止H2O2损害SH-SY5Y细胞和通过花生四烯酸网络调整的LPS诱导的损伤及其后的p38 MAPK和NF-κB信号。这些发现是我们考虑将HOEC作为预防和治疗涉及氧化应激或/和炎症的神经退行性疾病的候选药物。
关键词: 老年痴呆,HOEC,氧化应激,神经炎症,神经退行性疾病,MAPK,NF-κB。
Current Alzheimer Research
Title:Neuroprotection of (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Against Hydrogen Peroxide and Lipopolysaccharide Induced Injury via Modulating Arachidonic Acid Network and p38-MAPK Signaling
Volume: 12 Issue: 9
Author(s): Jiao-Ning Shen, Liu-Xin Xu, Lei Shan, Wei-Dong Zhang, Hong-Lin Li and Rui Wang
Affiliation:
关键词: 老年痴呆,HOEC,氧化应激,神经炎症,神经退行性疾病,MAPK,NF-κB。
摘要: Oxidative stress and neuroinflammation are highly relevant to the pathological processes of various neurodegenerative diseases including Alzheimer’s disease (AD). (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate (HOEC), a novel 5-lipoxygenase inhibitor, was isolated from the whole plant of Incarvillea mairei var granditlora (Wehrhahn) Grierson. In this study, we investigated the protective effect of HOEC on hydrogen peroxide (H2O2) and lipopolysaccharide (LPS) -induced cytotoxicity and neuroinflammation in vitro and in vivo. MTT assay, LDH release assay, morphological observation and Hoechst 33342/PI dual staining followed by EIA, immunofluorescence staining and Western Blotting analysis were performed to elucidate the neuroprotective effect of HOEC. Treatment with HOEC at various concentrations prior to H2O2 exposure significantly enhanced cell viability, decreased LDH release, prevented cell morphologic changes and apoptosis. Instead of PGE2 reduction, HOEC markedly inhibited the production of LTB4 and suppressed the macrophage-mediated neurotoxicity. Western blotting and immunofluorescence staining showed that HOEC inhibited H2O2-induced p38 phosphorylation and NF-κB activation. Neuroprotective effect of HOEC was abolished by a p38 inhibitor. Further in vivo studies of LPS-induced neuroinflammation confirmed the anti-inflammatory effects of HOEC. These findings that HOEC protects SH-SY5Y cells from H2O2 and LPS-induced injury via arachidonic acid network modulation followed by p38 MAPK and NF-κB signaling, might make HOEC be considered as a therapeutic candidate for prevention and treatment of neurodegenerative diseases involving oxidative stress or/and inflammation.
Export Options
About this article
Cite this article as:
Jiao-Ning Shen, Liu-Xin Xu, Lei Shan, Wei-Dong Zhang, Hong-Lin Li and Rui Wang , Neuroprotection of (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Against Hydrogen Peroxide and Lipopolysaccharide Induced Injury via Modulating Arachidonic Acid Network and p38-MAPK Signaling, Current Alzheimer Research 2015; 12 (9) . https://dx.doi.org/10.2174/156720501209151019111244
DOI https://dx.doi.org/10.2174/156720501209151019111244 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Adiponectin Signaling Pathway as a Novel Pharmacological Target
Mini-Reviews in Medicinal Chemistry Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
Current Molecular Pharmacology MicroRNA Therapeutics for Cardiac Regeneration
Mini-Reviews in Medicinal Chemistry Increasing Bcl-2 and Neuroglubin Expression in Hypoxic Hippocampal Neurons under Hypoxia Preconditioning and in 3-n-butylphalide Treated Cells under Oxygen Glucose Deprivation/Reoxygenation
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Study on the Formation Mechanisms of the Degradation Products of Salvianolic Acid A
Current Analytical Chemistry Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine Editorial (Hot Topic: Pharmacotherapy During Percutaneous Coronary Intervention in Acute Myocardial Infarction)
Cardiovascular & Hematological Agents in Medicinal Chemistry Heme Oxygenase Overexpression Attenuates Glucose-Mediated Oxidative Stress in Quiescent Cell Phase: Linking Heme to Hyperglycemia Complications
Current Neurovascular Research The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Current Alzheimer Research The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets The Potential Protective Effect of Orange Peel and Selenium against 17β-Estradiol- Induced Chronic Non-Bacterial Prostatitis in Rats
Anti-Cancer Agents in Medicinal Chemistry Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
Current Medicinal Chemistry Cerebrovascular Complications of Diabetes: Focus on Stroke
Endocrine, Metabolic & Immune Disorders - Drug Targets Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases
Current Pharmaceutical Design New Antihypertensive Drugs Under Development
Current Medicinal Chemistry Screening of NO Inhibitor Release Activity from Soft Coral Extracts Origin Palu Bay, Central Sulawesi, Indonesia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry